Investment Thesis — 3M Company
The market overstates litigation and operational risks, missing that 3M’s restructuring and divestitures are quietly improving cash flow quality and future earnings visibility. Investors are pricing in perpetual headline risk, but the underlying industrial franchise is stabilizing faster than consensus expects.
Catalysts
- Finalization of major litigation settlements
- Completion of key divestitures and restructuring
- Supply chain normalization driving margin expansion
Risk Factors
- Unexpected escalation in litigation costs
- Restructuring fails to deliver margin improvement
- Dividend cut undermines investor trust
Key Debates
Remaining 3M's P/E expands to 24x by Q4 2024
PFAS settlement clarity re-rates MMM 10% by Q4 2024
Core revenue growth exceeds 2% by H1 2025